CREON 1224 Pill - orange clear capsule-shape, 22mm

Generic Name: pancrelipase

Pill with imprint CREON 1224 is Orange / Clear, Capsule-shape and has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease. It is supplied by Solvay Pharmaceuticals Inc.

Creon is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1224

Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease CREON 1224

Creon

Generic Name: pancrelipase
Imprint: CREON 1224
Strength: 120,000 units amylase / 24,000 units lipase / 76,000 units protease
Color: Orange / Clear
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Digestive enzymes
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Solvay Pharmaceuticals Inc.
National Drug Code (NDC): 00032-1224
Inactive Ingredients: cetyl alcohol, dimethicone, triethyl citrate, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, hypromellose phthalate (31% phthalate, 40 cst)
Note: Inactive ingredients may vary.